Ben Bronstein - 27 Jun 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Ben Bronstein
Issuer symbol
ALDX
Transactions as of
27 Jun 2023
Transactions value $
$5,301
Form type
4
Filing time
29 Jun 2023, 16:23:44 UTC
Previous filing
09 Jun 2022
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Options Exercise $5.3K +9.6K +51.51% $0.55* 28.2K 27 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Options Exercise $0 +9.6K $0.00* 0 27 Jun 2023 Common Stock 9.6K $0.55 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option is fully vested.